Tanya Frost

Tanya Frost, R.N. is a seasoned professional in the healthcare industry with extensive experience in the biopharmaceutical sector. Currently serving as the Regional Account Director for US Market Access and Value in Rare/Ultra Rare Disease at Amgen since its acquisition of Horizon Therapeutics, Tanya manages payor access and collaborates with regional payors to enhance market strategies across a portfolio of therapies. Prior to this role, Tanya held various positions, including Associate Director for Sites of Care at Horizon and Executive Area Business Manager at Sanofi Genzyme, where successful relationships with healthcare executives led to improved operational efficiencies. With experience in oncology and nephrology sales at companies such as Coherus BioSciences and Clovis Oncology, and a strong foundation as an Executive Biopharmaceutical Representative at Amgen, Tanya has consistently driven market growth and improved patient access to innovative treatments. Educational background includes a Bachelor of Science from Linfield University and an Associate's degree in Nursing from Community Colleges of Spokane.